CPIX
NASDAQ · Pharmaceuticals
Cumberland Pharmaceuticals
$3.16
+0.11 (+3.61%)
Open$2.95
Previous Close$3.05
Day High$3.19
Day Low$2.94
52W High$6.27
52W Low$1.85
Volume—
Avg Volume88.8K
Market Cap42.40M
P/E Ratio—
EPS$-0.19
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+1,021.8% upside
Current
$3.16
$3.16
Target
$35.45
$35.45
$27.92
$35.45 avg
$53.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 44.13M | 43.28M | 7.91M |
| Net Income | -2,810,607 | -2,481,163 | 1.22M |
| Profit Margin | -6.4% | -6.1% | 15.4% |
| EBITDA | 1.34M | 1.25M | 2.16M |
| Free Cash Flow | — | — | 556.1K |
| Rev Growth | +2.0% | +2.0% | +3.2% |
| Debt/Equity | 0.21 | 0.21 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |